Related Experiment Video
Updated: Jun 5, 2026

Live-cell Video Microscopy of Fungal Pathogen Phagocytosis
Published on: January 9, 2013
The pH-regulated antigen 1 of Candida albicans binds the human complement inhibitor C4b-binding protein and mediates
Shanshan Luo1, Anna M Blom2, Steffen Rupp3
1From the Department of Infection Biology and.
Insights
Candida albicans uses Pra1 to bind human C4b-binding protein (C4BP), evading the immune system. This interaction helps the fungus evade complement-mediated destruction.
Area of Science:
- Immunology
- Microbiology
- Biochemistry
Background:
- Candida albicans employs immune evasion strategies to survive in the host.
- Human complement inhibitors like C4b-binding protein (C4BP) are crucial targets for microbial immune evasion.
Purpose of the Study:
- To identify and characterize the interaction between Candida albicans pH-regulated antigen 1 (Pra1) and human C4BP.
- To determine the role of the Pra1-C4BP interaction in Candida albicans immune evasion.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA)
- Isothermal titration calorimetry (ITC)
- Recombinant protein expression
- Candida albicans strain manipulation (overexpression and knockout)
Main Results:
- Pra1 directly binds C4BP through ionic interactions.
- Binding sites were localized to CCP4, CCP7, and CCP8 domains of C4BP.
- C4BP bound to Pra1 retains its complement-inhibitory activity.
- Pra1 facilitates simultaneous binding of C4BP and Factor H.
- Pra1 overexpression enhances C4BP surface deposition on C. albicans, while Pra1 knockout reduces it.
- C4BP captured by C. albicans inhibits complement deposition (C4b, C3b) and maintains cofactor activity.
Conclusions:
- Candida Pra1 is the first identified fungal protein that binds C4BP.
- Pra1 binding to C4BP mediates human complement control, aiding Candida albicans immune and complement evasion.
Abstract:
Candida albicans binds and utilizes human complement inhibitors, such as C4b-binding protein (C4BP), Factor H, and FHL-1 for immune evasion. Here, we identify Candida pH-regulated antigen 1 (Pra1) as the first fungal C4BP-binding protein. Recombinant Pra1 binds C4BP, as shown by ELISA and isothermal titration calorimetry, and the Pra1-C4BP interaction is ionic in nature. The Pra1 binding domains within C4BP were localized to the complement control protein domain 4 (CCP4), CCP7, and CCP8. C4BP bound to Pra1 maintains complement-inhibitory activity. C4BP and Factor H bind simultaneously to Candida Pra1 and do not compete for binding at physiological levels. A Pra1-overexpressing C. albicans strain, which had about 2-fold Pra1 levels at the surface acquired also about 2-fold C4BP to the surface, compared with the wild type strain CAI4. A Pra1 knock-out strain showed ∼22% reduced C4BP binding. C4BP captured by C. albicans from human serum inhibits C4b and C3b surface deposition and also maintains cofactor activity. In summary, Candida Pra1 represents the first fungal C4BP-binding surface protein. Pra1, via binding to C4BP, mediates human complement control, thereby favoring the immune and complement evasion of C. albicans.
Related Concept Videos
Complement System
Candidiasis
Antifungal Agents
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
